Press "Enter" to skip to content

Canadian Cannabis: Why This Penny Stock Is 'Arguably The Best Value'

Top Canadian cannabis stocks, including Tilray Inc (NASDAQ: TLRY), Aphria Inc (NASDAQ: APHA) and Aurora Cannabis Inc (NYSE: ACB), have been red-hot in the last six months.

On Friday, Cantor Fitzgerald analyst Pablo Zuanic said Canadian cannabis penny stock Auxly Cannabis Group Inc (OTCQX: CBWTF) is “arguably the best value” among Canadian legal producers.

The Auxly Analyst: Zuanic has an Outperform rating and 69-cent price target for Auxly, representing more than 100% upside from its current level of around 30 cents.

Related Link: 6 Long-Term Themes Cannabis Investors Should Watch

The Auxly Thesis: Auxly is now the fifth-largest Canadian LP in terms of domestic recreational sales, accounting for about 4% market share in the fourth quarter of 2020.

Hifyre data suggests Auxly’s retail sales dropped about 10% in the first quarter of 2021 in what was a difficult quarter for the Canadian market as a whole.

Vapes represent about 71% of Auxly’s sales, and Zuanic estimates the company holds about 21% market share in the segment. Flower sales accounts for another 12% of Auxly’s business.

The company’s management has suggested Auxly will reach break-even EBITDA by the end of 2021.

“In our view, fundamentals are not reflected in the valuation (1.5x CY22E sales vs. 6-16x for the four larger LPs (based on our estimates), nor is the optionality from Imperial Tobacco (MB.LON/nc) owning convertible debt that could give it a 19.9% stake in the company,” Zuanic said.

The analyst said he anticipates Auxly will list on a U.S. exchange at some point, which should be a bullish catalyst for the stock.

He also said Auxly has relatively low execution risk compared to other mid-sized Canadian cannabis companies given its strong 2020 numbers, including 45% sequential growth in the fourth quarter.

Benzinga’s Take: Cannabis stocks will likely continue to be volatile in the near term while the industry matures. Long-term investors should monitor the progress of U.S. state-by-state and federal legalization efforts and should consider diversifying into several different U.S. and Canadian names rather than putting all their cannabis eggs in one basket.

© 2021 Benzinga does not provide investment advice. All rights reserved.

This post was originally published on this site

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *